Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium Currents
- 6 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (1) , 26-29
- https://doi.org/10.1161/01.cir.0000109484.00668.ce
Abstract
Background— Cases of QT prolongation, torsades de pointes, and sudden death have been reported with arsenic trioxide (As 2 O 3 ), a highly effective agent for acute promyelocytic leukemia. In this study, we evaluated the effects of As 2 O 3 on repolarizing cardiac ion currents. Methods and Results— In HERG- or KCNQ1+KCNE1-transfected CHO cells (n=32; total), As 2 O 3 caused concentration-dependent block of both I Kr and I Ks , with an IC 50 for tail current block of 0.14±0.01 μmol/L for I Kr and 1.13±0.06 μmol/L for I Ks . In contrast to other QT-prolonging drugs, As 2 O 3 also activated a time-independent current that additional experiments identified as I K-ATP . Conclusions— As 2 O 3 blocks both I Kr and I Ks at clinically relevant concentrations. On the other hand, it also activates I K-ATP , which maintains normal repolarization. We infer that variability in the extent of QT interval prolongation and onset of ventricular arrhythmias during arsenic therapy represents competing effects to block and activate multiple repolarizing potassium currents.Keywords
This publication has 15 references indexed in Scilit:
- Effect of Arsenic Trioxide on QT Interval in Patients With Advanced MalignanciesJournal of Clinical Oncology, 2003
- Phosphorylation of the I Ks Channel Complex Inhibits Drug BlockCirculation, 2003
- Direct cardiac effects of As2O3 in rabbits: evidence of reversible chronic toxicity and tissue accumulation of arsenicals after parenteral administrationToxicology and Applied Pharmacology, 2003
- Prolongation of cardiac repolarization by arsenic trioxideBlood, 2002
- Assembly Limits the Pharmacological Complexity of ATP-sensitive Potassium ChannelsPublished by Elsevier ,2002
- Drug Block of I Kr : Model Systems and Relevance to Human ArrhythmiasJournal of Cardiovascular Pharmacology, 2001
- United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaJournal of Clinical Oncology, 2001
- Torsades de pointes in 3 patients with leukemia treated with arsenic trioxideBlood, 2001
- Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic LeukemiaAnnals of Internal Medicine, 2000
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998